SCHEMBL23564396

SCHEMBL23564396

CCC1CCN(SC)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13674009 0.78 NCF1 (0.56) NCF1
SCHEMBL22080010 0.78 ESR1 (0.32) NCF1
SCHEMBL26059718 0.76 PDK1 (0.32)
SCHEMBL24498429 0.75 L3MBTL1 (0.39)
SCHEMBL23442240 0.75 HTT (0.34)
SCHEMBL20084193 0.75 OPRK1 (0.30)
SCHEMBL25468553 0.75
SCHEMBL24258358 0.74
SCHEMBL23489042 0.73 BCHE (0.31)
SCHEMBL26849339 0.72 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147329-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION AND METHODS THEREOF GENENTECH, INC. (US) 2023-08-03 WO disclosed
WO-2022133285-A1 MOLECULES AND METHODS RELATED TO TREATMNET OF DISORDERS ASSOCIATED WITH JAK-2 SIGNALING DYSFUNCTION ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2022-06-23 WO disclosed
WO-2021127499-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2021-06-24 WO disclosed